Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.5.2.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.5.2.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.38ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.38.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.38.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BT.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BT.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.55ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.55NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.76ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.76NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used